Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 09 tags : Cancer save search
Corcept Announces Presentation of Positive Results From Randomized, Controlled, Phase 2 Trial of Relacorilant in Patients With Recurrent Platinum-Resistant Ovarian Cancer at ESMO 2021
Published: 2021-09-09 (Crawled : 22:00) - biospace.com/
CORT | News | $23.0 3.14% 3.04% 1.9M
|
Health Technology
|
| O: 0.05%
H: 0.19%
C: -0.89%
presentation phase 2 positive results positive results cancer ovarian cancer trial
CG Oncology Announces Clinical Trial Collaboration with Bristol Myers Squibb to Evaluate Oncolytic Immunotherapy CG0070 in Combination with OPDIVO® (nivolumab) in Metastatic Urothelial Cancer
Published: 2021-09-09 (Crawled : 13:15) - biospace.com/
BMY | $48.99 -0.31% 0.41% 7.1M
|
Health Technology
|
| O: -0.74%
H: 0.49%
C: -1.33%
immunotherapy therapy collaboration cancer trial nivolumab
Veru Announces Oral Presentation of Updated Data from the Phase 1b/2 Sabizabulin Study in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 ESMO Congress
Published: 2021-09-09 (Crawled : 13:15) - biospace.com/
VERU | $1.275 0.39% 0.0% 2.6M
|
Health Technology
|
| O: -1.31%
H: 5.75%
C: 3.73%
GILD | $67.03 0.12% 0.12% 3.6M
|
Health Technology
|
| O: -0.33%
H: 0.06%
C: -1.44%
presentation prostate cancer phase 1 cancer phase 1b sabizabulin phase 2b
PDS Biotech Completes Enrollment of Lead-In Safety Cohort in VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
PDSB | $3.2 7.02% 6.56% 990K
|
Health Technology
|
| O: 0.59%
H: 6.23%
C: 1.56%
phase 2 cancer biotech iot trial keytruda enroll
FDA Grants Breakthrough Device Designation to the NovoTTF-200T™ System for Advanced Liver Cancer
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
NVCR | $12.055 1.9% 1.87% 600K
|
Health Technology
|
| O: 1.9%
H: 3.69%
C: 0.07%
fda cancer device liver granted grant designation
Aspira Women’s Health Kicks Off Ovarian Cancer Awareness Month by Further Establishing Itself as a Thought Leader in Ovarian Cancer
Published: 2021-09-09 (Crawled : 12:00) - globenewswire.com
AWH | $3.39 -3.14% -3.09% 7.8K
|
Health Technology
|
| O: 0.86%
H: 5.68%
C: 2.27%
women cancer ovarian cancer
Olema Oncology to Present Data on OP-1250 at the 2021 JCA-AACR Precision Cancer Medicine International Conference
Published: 2021-09-09 (Crawled : 12:00) - globenewswire.com
OLMA | $10.0 1.32% 1.1% 580K
|
Health Technology
|
| O: 0.64%
H: 2.06%
C: -2.69%
cancer conference
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
ZAPP | $4.44 50.2% 33.12% 370K
|
n/a
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
Your saved searches
Save your searches and get alerts when important news are released.